Trade Report: The CRH Medical Corp (CRHM) Rating Reiterated by RBC Capital Markets

The CRH Medical Corp (CRHM) Rating Reiterated by RBC Capital Markets

CRH Medical Corp (NASDAQ:CRHM)‘s stock had its “outperform” rating reissued by investment analysts at RBC Capital Markets in a research report issued to clients and investors on Saturday. They currently have a $6.50 price objective on the stock. RBC Capital Markets’ price target points to a potential upside of 50.46% from the stock’s current price.

A number of other analysts have also recently issued reports on CRHM. Canaccord Genuity reiterated a “buy” rating on shares of CRH Medical Corp in a research note on Thursday, June 16th. Zacks Investment Research cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Monday, September 5th. Finally, CIBC reiterated an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th.

CRH Medical Corp (NASDAQ:CRHM) opened at 4.32 on Friday. The firm’s 50-day moving average is $3.80 and its 200-day moving average is $3.55. CRH Medical Corp has a 1-year low of $2.15 and a 1-year high of $4.39.

10/08/crh-medical-corp-crhm-rating-reiterated-by-rbc-capital-markets.html

Several institutional investors have recently added to or reduced their stakes in the stock. Hillsdale Investment Management Inc. purchased a new position in CRH Medical Corp during the second quarter worth approximately $3,661,000. Stifel Financial Corp purchased a new position in CRH Medical Corp during the second quarter worth approximately $3,051,000. Pacific Ridge Capital Partners LLC purchased a new position in CRH Medical Corp during the second quarter worth approximately $1,985,000. Mackenzie Financial Corp purchased a new position in CRH Medical Corp during the second quarter worth approximately $1,899,000. Finally, Sentry Investments Corp. raised its position in CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock worth $1,943,000 after buying an additional 7,300 shares in the last quarter.

About CRH Medical Corp

Related posts

Leave a Comment